Loading...
Loading...
MACK| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 0.0K |
| Gross Profit | 0.0K |
| Operating Expense | 486.0K |
| Operating I/L | -486.0K |
| Other Income/Expense | 8.0K |
| Interest Income | 8.0K |
| Pretax | -478.0K |
| Income Tax Expense | -16.0K |
| Net Income/Loss | -462.0K |
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative cancer treatments. Leveraging its expertise in nanotechnology and precision medicine, the company focuses on creating targeted therapies for patients with unmet medical needs. Merrimack Pharmaceuticals generates revenue through the sale of its proprietary drugs and through collaborations with other pharmaceutical companies for the development and commercialization of new therapies.
